Keywords: januvia, gets, thumbs, up, chmp, merck, sharp

Januvia gets thumbs up from CHMP

Article | 05 February 2007

Print This

Merck, Sharp & Dohme, the UK subsidiary of Merck & Co, says that Januvia (sitagliptin), its treatment for type 2 diabetes, is the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in